Literature DB >> 32914284

Helicobacter cinaedi-Associated Refractory Cellulitis in Patients with X-Linked Agammaglobulinemia.

Kento Inoue1, Saeko Sasaki2, Takahiro Yasumi3, Kohsuke Imai4, Takashi Kusunoki2, Tomohiro Morio1, Hirokazu Kanegane5.   

Abstract

X-linked agammaglobulinemia (XLA) is characterized by severe or recurrent infections, hypogammaglobulinemia, and circulating B cell deficiency. The frequent pathogens seen in patients with XLA include Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, and enterovirus as well as Campylobacter and Helicobacter species. Here, we describe two patients with XLA who developed cellulitis and bacteremia caused by Helicobacter cinaedi even when administered an appropriate immunoglobulin replacement therapy. H. cinaedi may be difficult to isolate using a conventional blood culture system and could be identified by sequence analysis and mass spectrometry. H. cinaedi infection causes recurrent symptoms frequently, and patients require a long course of antibiotic treatment. Recently, the case of non-H. pylori Helicobacter (NHPH) infection such as H. cinaedi and H. bilis infection is increasing in number in patients with XLA. Systemic NHPH infection should be suspected, and extensive microbiological analysis should be performed to appropriately treat patients with XLA who present with fever and skin lesions.

Entities:  

Keywords:  Bacteremia; Helicobacter cinaedi; X-linked agammaglobulinemia; cellulitis

Year:  2020        PMID: 32914284     DOI: 10.1007/s10875-020-00830-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  2 in total

1.  Agammaglobulinemia.

Authors:  O C BRUTON
Journal:  Pediatrics       Date:  1952-06       Impact factor: 7.124

2.  Bacteremia caused by Helicobacter cinaedi in an AIDS patients.

Authors:  C C Hung; P R Hsueh; M Y Chen; L J Teng; Y C Chen; K T Luh; C Y Chuang
Journal:  J Formos Med Assoc       Date:  1997-07       Impact factor: 3.282

  2 in total
  3 in total

1.  Campylobacter infection in 4 patients treated with ibrutinib.

Authors:  Boris Sorin; Julien Vigneron; Jehane Fadlallah; Johanna Mondesir; Claire Fieschi; Eric Oksenhendler; Lionel Galicier; Marion Malphettes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-03-18       Impact factor: 3.267

Review 2.  Update on Infections in Primary Antibody Deficiencies.

Authors:  Yesim Yilmaz Demirdag; Sudhir Gupta
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

Review 3.  Infections With Enterohepatic Non-H. pylori Helicobacter Species in X-Linked Agammaglobulinemia: Clinical Cases and Review of the Literature.

Authors:  Carolina Romo-Gonzalez; Juan Carlos Bustamante-Ogando; Marco Antonio Yamazaki-Nakashimada; Francisco Aviles-Jimenez; Francisco Otero-Mendoza; Francisco Javier Espinosa-Rosales; Sara Elva Espinosa-Padilla; Selma Cecilia Scheffler Mendoza; Carola Durán-McKinster; Maria Teresa García-Romero; Marimar Saez-de-Ocariz; Gabriela Lopez-Herrera
Journal:  Front Cell Infect Microbiol       Date:  2022-02-04       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.